Owlet (OWLT) Cash from Investing Activities (2020 - 2026)
Owlet (OWLT) reported Cash from Investing Activities of -$415000.0 for Q1 2026, down 277.27% year-over-year from $234102.6 in Q1 2025, and up 15.13% quarter-over-quarter from -$489000.0 in Q4 2025.
Owlet (OWLT) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Cash from Investing Activities data on file, last reported at -$415000.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$415000.0, down 277.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 49.64% YoY), and the FY2025 annual result was -$943000.0, down 23.92% from the prior year.
- Cash from Investing Activities climbed to -$415000.0 in Q1 2026 per OWLT's latest filing, from -$489000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$8000.0 in Q1 2023 and troughed at -$700000.0 in Q1 2022.
- A 5-year average of -$220176.5 and a median of -$160000.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities surged 98.86% in 2023, then plunged 4563.64% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$162000.0 in 2022, then jumped by 82.1% to -$29000.0 in 2023, then slumped by 500.0% to -$174000.0 in 2024, then plunged by 181.03% to -$489000.0 in 2025, then increased by 15.13% to -$415000.0 in 2026.
- Business Quant data shows OWLT's Cash from Investing Activities at -$415000.0 in Q1 2026, -$489000.0 in Q4 2025, and -$255000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Owlet | 127.76 Mn | 86.75 Mn | 12.24 Mn | -415,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -415,000.00 |
| Mar 31, 2026 | -415,000.00 |
| Dec 31, 2025 | -489,000.00 |
| Dec 31, 2025 | -489,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Jun 30, 2025 | -89,000.00 |
| Jun 30, 2025 | -89,000.00 |
| Mar 31, 2025 | -110,000.00 |
| Mar 31, 2025 | -110,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Dec 31, 2023 | -29,000.00 |